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ABSTRACT
Background Multiple sclerosis (MS) is estimated to affect 
2.8 million people worldwide, with increasing prevalence 
in all world regions (Walton et al). While there is no cure 
for MS, medication and lifestyle modifications can slow 
disease progression and enhance patients’ quality of 
life. The biopsychosocial model of health recognises 
important interactions among biological, psychological and 
social factors in illness, including those relating to illness 
management, which contribute to the experience of those 
diagnosed with MS.
Objective This qualitative, idiographic study aimed to 
explore the lived experiences of patients in the United Arab 
Emirates (UAE) diagnosed with S.
Methods Semistructured interviews were conducted with 
a purposive sample of eight patients with MS ranging in 
age from 25 to 56 years. All participants were residing 
in the UAE at the time of data collection. Interpretative 
phenomenological analysis was used to analyse the data.
Results Three superordinate themes were identified 
from patients’ candid accounts of their lives with MS, 
highlighting issues of illness management, acceptance 
and gratitude, and adaptive coping. These themes broadly 
illustrate biological, psychological and social aspects of 
patients’ MS experiences.
Conclusion The study emphasised the importance 
of adopting the biopsychosocial model to treat and 
manage MS. Additionally, it highlights the need for routine 
assessment and early, multidimensional approach with 
multidisciplinary team efforts to improve patients’ quality 
of life.
INTRODUCTION
A chronic demyelinating disease of the central 
nervous system, multiple sclerosis (MS) is 
estimated to affect 2.8 million people world-
wide, with increasing prevalence in all world 
regions.1 Although the exact cause of MS is 
still unknown, susceptibility to the disease is 
influenced by genetic, immunological and 
environmental factors.2–6 MS occurs more 
frequently in areas farther from the equator, 
including Canada, Denmark, Australia and 
New Zealand.7 Although there is currently no 
cure for MS, treatments can help modify or 
slow disease progression, treat clinical exacer-
bations and generally improve overall health 
and physiological function.4 Lifestyle factors 
such as smoking and obesity are known to 
increase disability progression.8 9 In combi-
nation with disease- modifying medications, 
rehabilitation strategies can manage MS 
symptoms. Such rehabilitation programmes 
focus on treating physiological and cognitive 
deficits, designed to improve and maintain 
one’s ability to perform daily life activities.10 
Alongside biomedical treatment, studies 
increasingly highlight the need for a multi-
dimensional approach with multidisciplinary 
team efforts to treat MS due to its complexity, 
unpredictability and the invisibility of some 
of its symptoms.11–13
The biopsychosocial (BPS) model, an 
approach to illness diagnosis and manage-
ment, is guided by a multidimensional view 
of an illness’s biomedical, psychological 
and social features.14 15 In clear contrast 
with the biomedical model, the BPS model 
is both a philosophy and a medical para-
digm that proposes the need for human-
ising and empowering patients through the 
use of empathy and compassion in medical 
Strengths and limitations of this study
 ► This qualitative study highlights the experiences of 
people living with multiple sclerosis in the United 
Arab Emirates, which has received comparatively 
less research attention than in ‘Western’ countries.
 ► The idiographic approach permitted in- depth explo-
ration of the participants’ lived experiences, absent 
in previous quantitative accounts of the same topic 
in the United Arab Emirates.
 ► Given the qualitative nature of this study, generalis-
ability of findings was not a focus of this research.
 ► The various personal and disease characteristics of 
participants may have introduced unforeseen het-
erogeneity into the sample.
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practice.15 The model encourages attention to the 
complexities of interactions among physiological, psycho-
logical and social aspects of an illness in determining 
appropriate and effective responses to primary and 
secondary symptoms. Examples of psychosocial factors 
include mood, personality, behaviour, coping, social 
support, family relationships and socioeconomic factors. 
These factors contribute to the overall experience of 
patients diagnosed with MS. Various aspects of life with 
MS have been examined through a BPS lens, including 
pain,16 17 fatigue,18 19 resilience20 21 and quality of life.12 
While the disease is consistently associated with reduced 
quality of life, studies over several decades show that 
disease severity alone does not fully explain this.12 22 23 
Such arguments are consistent with the BPS model of 
health, which considers the simultaneous implication 
of biological, psychological, and social aspects to fully 
understand and appreciate the patient’s subjective well- 
being, quality of life and overall functioning.12
Negative experiences of people living with MS have 
been identified across various BPS domains. These 
include self- enforced social distancing as a means of 
protection,24 25 the impact of fatigue on communica-
tion,26 the disease’s impact on perceived dignity27 and 
personal relationships.28 Irvine et al29 discussed how iden-
tity is redefined following MS diagnosis, and how initial 
functional challenges can ameliorate over time, with 
adjustment to the condition. Similarly, Strickland et al30 
presented a phenomenological account of how people 
living with MS reflect on the transition from their predi-
agnosis to postdiagnosis selves and learn to live with their 
illness. The impact on one’s sense of self might not be 
inevitable31 32; it may depend on the extent to which MS 
symptoms impact the daily roles that were integral to the 
person’s prediagnosis life.32 Interestingly, some positives 
have been shown to emerge from diagnosis with chronic 
illness, including ‘post- traumatic growth’.33 In MS, this 
includes diverse outcomes such as increased compas-
sion and mindfulness, improvements in family relations 
and lifestyle,34 health gains and increased spirituality.35 
Multiple studies have also examined quality of life,12 22 23 
meaning- making31 and growth33 in individuals living with 
MS and other chronic illnesses.
In the United Arab Emirates (UAE) and the wider 
Middle East and North Africa (MENA) region, quan-
titative studies focusing on illness management and 
patient care services highlight the lack of a multidi-
mensional approach using multidisciplinary teams in 
treating neurological disorders and common comorbid-
ities.36 37 Unlike the western world, the MENA region 
is still limited in providing holistic care to patients with 
chronic illnesses.38–44 The current study aimed to quali-
tatively explore patients’ individual accounts and subjec-
tive experiences of living with MS in the UAE. By doing 
so, the objective was to solidify the need for a multidi-
mensional approach to providing care in the UAE and 
the wider MENA region, which may enhance patients’ 
quality of life.36 37 In this study, the term multidimensional 
refers to the provision of patient care using the BPS 
model of health. By looking at person- specific factors 
and the concept of health in more depth than merely 
viewing it as the absence of illness, an insight into how 
people navigate their lives with this chronic illness may 
be gained. Through a phenomenological approach, the 
study explored factors that may play a substantial role in 
determining the quality of life and overall adjustment of 
patients living with MS in the UAE.
METHODS
Design
This study used a qualitative, idiographic approach to 
explore participants’ experiences of living with MS. A 
phenomenological approach informed all aspects of 
the study, from conceptualisation to data collection, 
analysis and presentation of findings. Through this 
window into the subjective, lived experiences of partici-
pants, it is possible to identify new meanings, which can 
inform how these experiences are understood by health 
professionals.45
Sampling and participants
Researchers recruited a small, homogeneous, purposively 
selected sample as per the requirements of interpretative 
phenomenological analysis (IPA).46 The study included 
eight participants diagnosed with MS (International Clas-
sification of Diseases (ICD-10: G35) using the McDonald 
diagnostic criteria.47 They ranged in age from 25 to 56 
years and were representative of patients living with the 
same type of condition in the same geographic location. 
In addition to a clinical diagnosis of MS, the inclusion 
criteria were that participants were over 18 years and did 
not have other diagnosed neurological disorders. Demo-
graphic and clinical details of patients are given in table 1.
Data collection
All participants provided informed consent. One- to- one, 
semistructured interviews were conducted with partici-
pants at their preferred location. Semistructured inter-
views are compatible with the chosen analysis,48 allowing 
the participants and the researcher to explore new, 
potentially unexpected discussion topics. Interviews, 
lasting approximately 30 min, were audiorecorded and 
were carried out by SAK, a clinical research professional 
with background in psychology. The interviews consisted 
of nine questions, allowing for prompts. The interview 
guide is provided in figure 1.
Data analysis
The idiographic approach of IPA46 49 was used to analyse 
the data. This iterative process involved familiarisation 
with data, identification of descriptive, linguistic, and 
conceptual codes, and the development of emergent 
themes and superordinate themes per case. These steps 
were repeated for each participant. Once completed, a 
master table of superordinate themes was identified for 
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the group. Researchers adopted a data- driven analytical 
approach and findings were viewed in light of the BPS 
model of health. Doing so allowed the researchers to 
explore, in- depth, the lived experiences of participants.50 
LH, a chartered psychologist, conducted data analysis in 
Microsoft Word. The findings were subsequently audited 
by SAK. The coconstruction of meaning and the double 
hermeneutic of IPA (wherein the researchers make sense 
of how the participants reflect on their own experiences) 
was intrinsic to this study. Both researchers engaged in 
critical reflexivity to examine how their own experiences 
and expectations might impact the analytical process to 
ensure that the participants’ voices were heard. Addition-
ally, rigour of this study was enhanced in consultation 
with the Consolidated Criteria for Reporting Qualitative 
Research checklist.51
Patient and public involvement
Patients and the public were not involved in the design or 
conduct of this study.
RESULTS
Respondents spoke candidly about their experiences of 
living with MS, discussing issues ranging from symptom 
management to perceptions of quality of life, and the 
types of support they received. Three superordinate 
themes were identified—‘Acceptance and management’, 
‘Counting one’s blessings’ and ‘Living differently’.
Acceptance and management
Participants varied greatly in their self- reported illness 
management. The heterogeneity of experiences is unsur-
prising, given that MS does not have a single, simple 
trajectory. Symptoms experienced by some (eg, fatigue, 
balance issues, numbness), were absent for others. Several 
patients engaged in a range of positive health behaviours, 
and all but one reportedly took disease- modifying thera-
pies (DMTs); they attributed physical and psychological 
improvements to their adherence to treatment and a 
Table 1 Demographic and clinical characteristics of participants
Pseudonym Sex Age range Country of origin
Time since diagnosis 
(in years) Comorbidities






Aliyah F 25–34 United Arab Emirates 8 Anaemia
Unspecified disease of the liver
Vitamin D deficiency




Lokesh M 55–64 India 13 Anaemia
Anxiety disorder
Vitamin D deficiency
Imad M 35–44 Iraq 6 None
Rashid M 25–34 Kingdom of Saudi Arabia 10 Major depressive disorder
Vitamin D deficiency




Killian M 25–34 Ireland 6 Major depressive disorder
Anxiety disorder
Figure 1 Interview questions and prompts.
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change in their overall attitude towards their diagnoses. 
However, others reported non- adherence with central 
components of their treatment regimen, including not 
taking their medication as prescribed. One participant 
struggled with MS to an extreme extent, across physical, 
psychological and social domains, whereas several others 
displayed adjustment and acceptance. Their varying 
experiences of illness management are explored in this 
section.
Participants who had high expectations of their illness 
management were self- critical when they believed they did 
not reach this ideal. This was particularly evident among 
those who actively researched their condition, poten-
tial treatment options, and who made lifestyle changes. 
Several participants reported positive outcomes from 
attending physiotherapy or from self- directed exercise. 
Lokesh’s case illustrates this; discussing his engagement 
in physical activity as providing therapeutic benefits, he 
criticises his consistency:
Lokesh: I should be doing more exercise. I do yoga, I 
do meditation. That helps in flexibility.
Interviewer: You’ve seen results?
Lokesh: I see results when I don’t do it for a while, I 
could feel that I’m much worse.
Interviewer: I see. How long have you been doing 
this?
Lokesh: Since the beginning.
Even if self- critical, Lokesh’s MS management, which 
began at the time of diagnosis, demonstrates an active 
coping style. Unlike some other participants, his early 
focus on treatment and his beliefs about its effectiveness 
may have helped Lokesh come to terms with his diag-
nosis. Throughout his interview, he projects an image of 
someone mindful of the illness’s demands, but who strives 
towards the best possible life with MS.
This drive towards health is shown by others, for 
example, Imad. The year following his diagnosis was char-
acterised by anxiety about death. However, the health 
behaviours he initiated brought about a positive sense of 
self: ‘I went like freakishly healthy for about six months… 
I stopped smoking, I stopped drinking.’ His use of the 
term ‘freakish’ alludes to his belief that he went too far, 
although he suggested that this is a typical reaction after 
MS diagnosis. While Imad notes that he does not exercise 
as much as in his early postdiagnosis days, he continues to 
engage in positive health behaviours.
I try to run three times a week. The only one I do con-
sistently is my long run on Friday morning because 
it’s Friday morning. I wake up, my wife and my kid 
are still passed out, and I go for my run. I think that’s 
the best thing.
Recognising the physical and psychological well- being 
benefits of lifestyle change, Imad advocates: ‘Nutrition, 
exercise is key. Exercise is key, I’m telling you. Anyone 
who has MS, get off your ass and work out.’
Even when benefits were evident, engaging in positive 
health behaviours such as diet or physiotherapy was a 
challenge for some. Aliyah admitted giving up on phys-
iotherapy, something that previously worked for her. 
Indeed, she believed that physiotherapy outperformed 
medication in treating her balance issue, stating ‘it was 
REALLY good.’ Although she stated that she had no 
free time after starting her postgraduate degree, she 
also admitted intentional non- adherence to the recom-
mended treatment.
Aliyah: I never miss the pills. But with the injections, 
I used to (laughs).
Interviewer: You used to forget, okay.
Aliyah: Not forget. I used to intentionally miss it. I 
hated it… I used an auto- injector, and every time I 
took the injection I used to be scared, even though I 
did it so many times. I hated it…
Interviewer: Have any of your doctors recommended 
a special diet to you?
Aliyah: Yeah, I actually, I've actually seen one of the di-
eticians here and she recommends a specific diet, but 
I have not, uh, I haven't like, uh… done it. You know 
why? Because I hate it when I have to think about it.
Aliyah did not share her diagnosis with work colleagues, 
not wanting small mistakes she might make at work to be 
‘blamed on MS.’ She further said that she hates it when 
people ‘blame MS for everything’, suggesting that this 
may be something she has encountered in other realms 
of her life. She believes that ignoring MS is a positive 
strategy in her illness management, stating ‘what I found 
good about myself is that I completely ignore that I have 
MS, like I completely ignore it, I think this helps.’ This 
type of avoidant coping was evident to varying degrees 
among four of the eight interviewees. By choosing to not 
think about MS or adopt lifestyle changes recommended 
by healthcare providers, they believed they retained a 
greater semblance of ‘normal’, old selves.
Rashid’s experience was markedly different; he neither 
coped actively nor was he able to ignore the physical and 
psychological toll MS had on his life. By his admission, he 
struggled to manage his MS:
It almost feels like I'm helpless. I’m having a vision 
problem. I used to drive cars, but now I can't. The 
balance and the depression is like a big… it’s a big 
deal. And I’m just trying to live. The problems affect 
me in a bad way… I don’t know what’s wrong, is it MS, 
or… Even when I feel happy it just feels like seconds.
With marked deterioration in his health, including 
major depressive disorder and loss of sight and balance, 
he shared his perception of obstacles that impacted his 
MS management. He no longer took DMT, citing the cost 
as prohibitive. However, he also alluded to side effects as 
a reason for stopping both MS therapy—‘… it was almost 
like giving me a heart attack, so it was not working’—and 
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treatment for his clinical depression—‘…I was like killing 
myself slowly.’
At the time of his interview, Rashid’s only regular inter-
actions were with his sole supporter, his mother—‘She’s 
my life actually. She’s my motivation, you know, to be 
alive.’ It was evident that Rashid had lost hope. Indeed, his 
story was characterised by loss—the loss of a young man’s 
social life, truncated education opportunities, and an 
ever- shrinking lifeworld. Describing himself as peaceful 
and quiet, but also as helpless and without friends, there 
was resignation in his narrative.
Contrasting the concept of loss, other accounts demon-
strated growth after diagnosis. Acceptance and manage-
ment may be initially challenging, but can improve over 
time. Anna shared encouraging feedback she received.
[The support group leader told me] ‘I've really seen 
a change in you this past couple of years, seeing you 
blossom. Taking charge of, managing your MS, vs just 
it being something that you were up against.” So, I 
can, I can say now, that I am doing a better job at 
managing it. But it’s not perfect, you know, it’s really 
hard.
The support group leader’s words acknowledged 
Anna’s efforts and reassured her that she was on the 
right path. There was a sense that, for Anna, manage-
ment was a process rather than an attainable, final 
state. She recognised that setbacks would happen, but 
that these would not defeat her. Anna’s change was not 
merely in the shift from life before MS to life after MS, 
but rather in her incremental MS management improve-
ments over time.
Counting one’s blessings
Participants’ narratives touched on their outlook on life 
with MS and the resultant changes in their interpersonal 
relationships. While all noted the impact of MS on their 
psychological well- being and relationships—new roles 
were undoubtedly negotiated with family and friends—
the changes wrought by MS were not always viewed 
negatively.
Six participants viewed themselves as lucky in several 
ways and reported gratitude for ‘blessings’ in their lives. 
Primarily, they appreciated support from family, friends, 
work colleagues, healthcare providers and others living 
with MS. Participants juxtaposed their experiences of 
those who support them with those who do not. Imme-
diate family members (parents, children, siblings, 
spouses) were often credited with being chief sources 
of support. In Batool’s case, her husband is the central 
figure in her support network.
My husband—he understands what I’m going 
through. Not fully, but he tries his best. He already 
let’s say (took) off some of my responsibilities, uh, 
and whenever he feels like I need rest he will say to 
me ‘just you go, I will do it.’ So, he’s really my main 
supporter.
She later elaborates on the redistribution of household 
responsibilities:
I have four kids, now I don’t do everything for them, 
okay, previously I was doing A to Z for them. Now I 
try to keep them independent as well, and align my 
husband with the activities that they have. It’s a re-
sponsibility that we both have.
This form of instrumental support allows Batool more 
time to rest and take care of her health. Identifying 
their ‘shared’ responsibility, she suggests that she and 
her husband are partners in their relationship and the 
management of her illness. Moreover, she appears to see 
an additional benefit in relinquishing some of her child-
care responsibilities; her children have become more 
self- reliant.
It was apparent that family was not always a source of 
support. Killian, one of the younger people interviewed 
in this study recalled his father’s immediate reaction to 
his diagnosis as ‘you’re going to f***ing die, you’re going 
to die.’ The detail with which Killian recalled his father’s 
words demonstrates the impact they had. There was an 
acute absence of support in Killian’s family home in the 
6 years following his diagnosis, which resulted in his devel-
opment of non- familial networks of support, comprising 
colleagues and friends. Killian referred to himself as 
‘lucky’ twelve times during his interview; reasons included 
his early diagnosis, the availability of effective medication, 
having a supportive work environment, and maintaining 
a positive attitude towards life with MS.
I'm lucky, because, you know stuff like, you're work-
ing, there're a lot of people with this ailment who 
are a lot worse. That in itself gives me some hope. 
Regardless of how anxious, what anxiety I have, I’m 
very lucky. That my treatment so far has been so good 
even through very tough times since my ailment, my 
diagnosis. So, I think I’m just thankful that I’ve been 
diagnosed when I was young, that’s it. I think I’m just 
lucky.
Killian’s maintenance of a positive outlook since his 
diagnosis was not easy for him. He refers to his innate 
tendency to view the glass as half empty and acknowl-
edges difficulties in maintaining an optimistic outlook. 
Viewing himself as fortunate relative to others with the 
same condition perhaps offsets the negativity and lack of 
hope he encountered at the time of his diagnosis.
One participant, Maya, reported being thankful for the 
illness itself. She regarded her diagnosis as a turning point 
in her husband’s relationship with God. A silver lining to 
her MS journey, she credited her illness with resolving his 
fractured faith.
I’m so happy, I’m actually so, so, so happy that I got 
MS. My husband has a ‘faith issue’, let’s put it that 
way, and, because of MS, he got so much faith. Look, 
my husband loves me so much, and I love him so 
much. He was so devastated and broken to pieces, 
6 Kassie SA, et al. BMJ Open 2021;11:e049041. doi:10.1136/bmjopen-2021-049041
Open access 
and he realized ‘She got a disease that has no cure! 
That nobody can do anything about.’ I couldn’t walk. 
I literally couldn’t walk. He had to carry me up and 
down the stairs… he was so broken apart and he real-
ized the only one who could fix it is God! ‘I better get 
back to him! I better get back on track.’ I’m so happy, 
you have no idea!
This acknowledgement of her husband’s devastation 
at her diagnosis is jarring when viewed alongside Maya’s 
happiness, particularly in the context of their loving rela-
tionship. However, ascribing a positive dimension to the 
MS diagnosis may have allowed Maya to cope, see a ‘bigger 
picture’, and make meaning from her new identity.
Living differently
The contrast between participants’ lives ‘before’ and 
‘after’, connected only by a liminal period of symptoms, 
was shared by five participants; they reported their lives 
had significantly changed since the diagnosis. Most 
viewed their illness and the resultant lifestyle changes 
as a burden. For some, the demands of symptoms, treat-
ment regimen, and the pressure to conform to healthy 
but restrictive lifestyles, were incompatible with the daily 
responsibilities that predated diagnosis.
Batool explained how the demands placed on her did 
not change after she was diagnosed with MS. She strug-
gled to reconcile the two ‘Batools’.
I don’t want people to compare me with my previous 
life, when I didn’t have MS. I did lots of changes in 
my life to accommodate myself with the disease. I just 
need people to understand that this is a new Batool, 
okay, that’s been trying to develop herself. But do not 
compare me please with the previous Batool that had 
no MS in her life.
This dichotomised self and Batool’s literal identifica-
tion as a ‘new’ person with a previous life illustrates the 
extent of the change caused by MS. While she explicitly 
recognises this change, it is evident that she believes 
others do not. She suggested that continuous demands 
placed on her by others stem from a lack of awareness 
about MS, an illness she refers to as ‘a monster in (my) 
head.’ Despite pressure to be her old self, and live up to 
her old responsibilities, Batool listens to her body and the 
physical implications of MS such as fatigue:
I feel like my body is calling, I have to, you have to 
get shut down, to go to sleep. Because I need energy, 
so, people might not understand, like if, especially 
you have family commitment, and, uh, like you are 
escaping from this responsibility, but for me, I try to 
ignore it.
Although invisible to others, symptoms of MS, especially 
fatigue, impacted day- to- day activities. Like Batool, Anna 
regarded MS as resulting in an ‘enforced slow- down’.
Cognitively it’s had a huge impact on my memory 
and my ability to focus. On a bad day I’ll get really 
terrible aphasia. Like, speaking as good as I am right 
now is a very good day for me (laughs), so, which 
is difficult when you’re trying to do something like 
class, you know, or talk to other people and things 
of that nature… On a bad fatigue day, I may spend 
all day napping, crawled up with my cats, and I al-
ways really feel guilty because I'm not able to do any 
housework or anything like that. But it’s also some-
thing that I've come to accept, that every now and 
then I'm just going to have a bad day like it’s just 
going to happen.
Previously minor activities were celebrated: ‘Hey, I have 
the energy to go out and meet with my friends. That’s 
fantastic, that means a lot to me.’ Although Anna reports 
feeling guilty because of her inability to manage some 
responsibilities, she shows a pragmatic acceptance of 
what she can and cannot do.
Diagnosed shortly after completing high school, 
Aliyah’s entire adult life has been impacted by MS. She 
shared that she did not have the opportunity to experi-
ence early adulthood in the same way as her peers. For 
example, she did not learn to drive, partially due to fears 
regarding balance, her most prevalent MS symptom. 
Despite asserting that she can still do the things she used 
to, Aliyah acknowledges a need to ‘think’ about her activ-
ities: ‘Before I wouldn’t think about it I would just take 
the stairs, now I have to think about it, like okay, how is 
my balance now, how is everything now? I have to, like, 
think about it.’ Apart from curtailing the independence 
associated with young adulthood, the absence of this rite 
of passage differentiates her from her peer group (those 
without MS) and others diagnosed with MS at a later age.
The experiences of participants illustrated above 
contrast with those of Killian, Lokesh and Imad, who 
acknowledge the challenges posed by MS, but refuse to be 
defined by their diagnosis. Killian reportedly experienced 
MS symptoms throughout his early life and was habitu-
ated to what he termed as the ‘fuzzy’ or ‘sticky’ sensation 
of MS. He did not indicate that the diagnosis changed 
his life course. Having lived with symptoms for several 
years before his diagnosis, he said ‘I don’t consider (MS) 
a disability, I don’t consider that an anomaly, I know how 
to go about my normal life. I stayed on a job, I went to 
university with it, it was normal.’ While he identifies diffi-
culties in life with this condition, he did not believe that 
MS should define his identity. He advises that others “… 
don’t let the MS consume you. It’s, it’s partially life. You 
have to manage it but it shouldn’t be the centre of your 
life.’
Lokesh also references the concept of normality, 
although a ‘new normal’, while acknowledging that his 
life has changed since the diagnosis:
Obviously you can’t do much, as much as you’d like 
to, in terms of exercise, in terms of walking, in terms 
of interacting with people. It’s not that I withdraw so-
cially, but I avoid too much interaction. I get tired. I 
feel like I need time for myself.
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Even though the physical implications of MS were 
apparent in his case (he had impaired gait and balance 
issues), he claimed ‘I don’t feel different. I behave and 
think normally. It’s just that physically you might not look 
the same.’ Lokesh says that his physical appearance as 
someone with an evident disability does not bother him, 
‘I don’t really care about what people think.’
Inner strength helps Imad, who views himself as 
someone who actively confronts life’s challenges. A self- 
professed optimist and extrovert, his attitude helped 
him deal with the shock of the diagnosis and manage the 
condition in the longer term.
I think I have a character of, you know, get things 
done. Get knocked down, get back up, do it again. 
I’m an entrepreneur, you know I’ve started my own 
business. It’s not easy, it’s not my first business, so, you 
know it’s a challenge that you have to take. You have 
two options, right? Either you’re going to sit there 
and cry in the corner, or you’re going to go do some-
thing about it, so I get up and do something about it.
Participants’ subjective experiences highlight vari-
ability in life with MS. Most, irrespective of the myriad 
symptoms, were practical in their outlook, recognising 
limitations but getting on with their lives. The psycho-
logical, physical and social impacts of MS were evident 
in narratives around change or, conversely, determined 
allegiance to prediagnosis identities.
DISCUSSION
This study explored the subjective experiences of patients 
living with MS in the UAE. An interpretative phenome-
nological approach49 was used to analyse participants’ 
transcribed interviews from which three superordinate 
themes emerged. These are ‘Acceptance and manage-
ment’, ‘Counting one’s blessings’ and ‘Living differently’. 
The themes exhibited the participants’ varied, subjective 
experiences of living with MS, but they also highlighted 
commonalities in physiological, psychological and social 
factors that characterise life with this chronic illness.
Under the theme of ‘acceptance and management’, 
participants touched on coming to terms with their diag-
nosis and dealing with the changes in their day- to- day lives 
due to physiological limitations caused by MS.29–32 Some 
achieved benefits from attending physiotherapy sessions 
to alleviate the physical symptoms, such as difficulties 
in balance and walking. All but one participant were on 
DMTs at the time of data collection, with some taking 
additional measures (eg, setting phone reminders for 
medication and implementing a strict exercise schedule) 
to adhere to their treatment. The theme ‘counting one’s 
blessings’ showcases how MS affected participants in both 
family and social circles. The impact of having (or not 
having) family or social support was palpably seen in 
almost all participants’ accounts, and is similarly evident 
in previous accounts within Western contexts.33 34 Those 
who reported family and social support viewed this as 
indispensable to their management of MS. Identity 
redefinition and self- prioritisation were noticeable in the 
theme ‘living differently’, wherein participants, to varying 
degrees, came to terms with their new postdiagnosis real-
ities. In some cases, participants had to carve out time 
and space for themselves, previously dedicated to other 
priorities. Personal attributes helped in this transition to 
a new life. Traits such as self- efficacy, self- acceptance and 
adaptive coping seemed to counteract negative illness 
perceptions and, in some cases, non- adherence to treat-
ment plans. This was also evident in previous studies 
wherein self- efficacy and locus of control were determi-
nants of health status, adherence to treatment, disease 
management, adjustment and health- related quality of 
life.52–56 Strober12 found that quality of life was positively 
associated with adaptive coping, perceived social support, 
self- efficacy and locus of control, and negatively associ-
ated with primary and secondary symptoms. Psychosocial 
adjustment to MS takes time; it is influenced by the self 
and by others, and it can impact the uptake of rehabilita-
tive opportunities.29 57 58 While the three identified themes 
are discussed separately, the biological, psychological 
and social elements in the lives’ of the participants were 
found to interact and often even overlap. The close and 
often complex interaction of biological, psychological 
and social factors in the participants’ journey is indicative 
of the need for a multidimensional approach involving 
multidisciplinary team efforts to support patients with 
MS.
The BPS model proposes the simultaneous consider-
ation of biological, psychological and social aspects of 
illness to fully understand and appreciate the patient’s 
subjective well- being, quality of life and overall func-
tioning.14 15 As reported in previous studies,12 17 18 a 
multidimensional approach with multidisciplinary team 
efforts is optimal to alleviating symptoms experienced by 
patients with MS, both primary and secondary. As evident 
among the current sample, fatigue was a prevalent, 
primary MS symptom.59 60 Fatigue can be debilitating; 
although it can interfere with life in professional and 
personal spheres, participants report that this symptom, 
similar to other invisible symptoms of MS, is not always 
recognised by others.13 Indeed, according to Ayache and 
Chalah,61 fatigue is frequently overlooked in clinical prac-
tice despite its high prevalence. While aware of the symp-
toms, clinicians may not fully appreciate the extent of its 
impact on patients.62 63 Secondary or comorbid symptoms 
of MS include psychosocial factors such as depression,64 
anxiety,64 unemployment due to physical dysfunction65 
or cognitive impairment,66 67 reduced quality of life68–72 
and reduced subjective well- being.12 Wollin et al70 found 
that depression, anxiety, self- efficacy, social support and 
stress explain 40% of the variance in quality of life when 
disease severity and duration were accounted for. Depres-
sion in MS is estimated at 30%, with anxiety around 
22.1%.64 The current sample included three people with 
a clinical diagnosis of major depressive disorder and four 
with general anxiety disorder. Implications of psychiatric 
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comorbidities include limited opportunities for employ-
ment,65 signalling a clear need to optimise patient care 
(eg, through provision of comprehensive psychological 
support). Additionally, patients with MS with cognitive 
impairment may face difficulty in finding/maintaining 
employment and engaging in social activities.66 67 71 72 In 
particular, two participants’ accounts of cognitive and 
physical impairment showed a stark impact on their social 
and occupational functioning. Some participants in the 
current sample expressed how much they value support 
from family and friends; often, a lack of MS awareness on 
the part of family members caused challenges for them. 
Particularly in the UAE and the wider MENA region, it 
is pertinent to increase public awareness through educa-
tion/awareness campaigns and set up social support 
groups in healthcare facilities to reduce misconceptions 
about MS36 39 and to indirectly facilitate illness manage-
ment.73 These findings, along with previous quantitative 
studies focusing on common primary and secondary MS 
symptoms affecting the general and health- related quality 
of life, emphasise the importance of a holistic approach 
to treating and managing MS.36 37 These and other similar 
studies highlight the importance of routine assessment 
and early, effective intervention in MS using the BPS 
model.
Limitations
The study is not without limitations. Although the study 
team aimed for sample homogeneity, it became evident 
throughout the interview process that there were clear 
differences among the subjects in terms of both disease 
characteristics and individual circumstances that may 
have introduced unforeseen heterogeneity to the sample. 
These differences include MS types, length of time since 
diagnosis, family dynamics, access to care and treat-
ment for comorbid conditions. For example, clinically 
diagnosed psychiatric and cognitive comorbidities were 
present in six out of the eight participants, including 
general anxiety disorders, major depressive disorder, 
adjustment disorder, mild cognitive deficit and mild 
memory deficit. Some participants were already receiving 
pharmacological and psychological treatment for the 
said comorbidities. As a result, we propose careful inter-
pretation of the results keeping such differences within 
context. Nevertheless, the heterogeneity observed in the 
sample is also representative of the characteristics of MS 
as a chronic illness; no two individuals are the same, even 
when carrying the same diagnosis.
Future research directions
This study focused on a small sample of UAE- based people 
living with MS. In light of how social support enhanced 
the participants’ illness management, further research 
attention should be directed towards perceived social 
stigma and invisible symptoms of MS, such as fatigue, 
pain, sleep disturbances and cognitive impairment. 
While fatigue was the most commonly reported symptom 
in the current study, pain is reported by approximately 
65%–92% of patients.74–77 Given that chronic pain has 
been shown to impact self- identity and increase the likeli-
hood of self- isolation,76 it may negatively affect psycholog-
ical well- being and MS management. Sleep disturbances 
are prevalent among those with MS,77 as is cognitive 
impairment.67 67 The hidden nature of these symptoms 
can result in family members, friends and employers 
showing limited understanding of MS patients’ need to 
‘live differently’, postdiagnosis.13 73 Future research may 
explore potential bidirectional relationships between 
psychosocial factors and such invisible symptoms, and the 
resultant impact on coping and quality of life.
IMPLICATIONS AND CONCLUSION
This qualitative study offers a unique insight into 
patients' lived experiences with MS and a deeper under-
standing of the need for a multidimensional approach to 
managing this chronic illness. Practitioners working with 
patients who have MS may consider the transferability 
of these findings. Within the clinical setting, a multidis-
ciplinary team approach (from initial diagnosis to long- 
term management) is optimal to address primary and 
secondary symptoms experienced by patients with MS. 
Clinical care providers could enhance existing provision 
to accommodate the multidimensional needs of patients 
with MS by enhancing patient care services, particu-
larly psychological/psychiatric treatments and supports. 
Through such advancements, it is hoped that health 
outcomes and quality of life for patients living with MS 
can be significantly improved.
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